Other Private Equity/Strategic Investments
Cipla to acquire 21% in medical test kits maker Achira for Rs.25-Cr
Listed pharma firm Cipla Ltd will acquire 21.05% stake for INR 25 crore in Achira Labs Pvt Ltd, which is engaged in development and commercialisation of point of care (PoC) medical test kits in India. This investment will facilitate a Cipla entity's strategic participation in the PoC diagnostics and AMR (antimicrobial resistance) space through the design, development, and manufacturing of microfluidics-based technologies. Bengaluru-based Achira is a medical diagnostics company and develops medical diagnostic products using microfluidic technology with an aim to bring sophisticated medical tests closer to the point of diagnosis, treatment and management.
From the Venture Intelligence PE-VC Deal Database: Between Dec-2009 and Nov-2015, Achira had raised over USD 3 M from Nadathur Holdings and Catamaran Ventures. (Subscribers to the database can login to view the valuation, deal structuring and other transaction details.)
Want to receive such news items in your inbox? Click Here to sign up for a trial.
